Galaxy Medicare

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE09A801015
  • NSEID: GML
  • BSEID:
INR
17.00
0.00 (0.00%)
BSENSE

Sep 01, 03:30 PM

BSE+NSE Vol: 8000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.0 k

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

72.98%

Why is Galaxy Medicare Ltd falling/rising?

02-Sep-2026

As of 01-Sep, Galaxy Medicare Ltd's stock price is stable at 17.00, but it has declined 3.68% over the past week and 21.30% year-to-date. Despite today's unchanged price, the stock shows a bearish trend relative to moving averages, although increased investor participation suggests growing interest.

As of 01-Sep, Galaxy Medicare Ltd's stock price is currently stable at 17.00, showing no change (0.00%). However, the stock has experienced a decline of 3.68% over the past week, while the benchmark Sensex has only decreased by 1.15%. Over the past month, the stock has increased by 1.49%, contrasting with a 1.34% drop in the Sensex. Year-to-date, Galaxy Medicare has seen a significant decline of 21.30%, compared to a 7.94% decrease in the Sensex.<BR><BR>Today's performance indicates that the stock is trading lower than its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a bearish trend in the stock's performance. However, there has been a notable increase in investor participation, with a delivery volume of 8,000 shares on August 28, which is 53.85% higher than the 5-day average delivery volume. This rise in participation may indicate growing interest among investors despite the overall downward trend.<BR><BR>In summary, while the stock price remains unchanged today, the overall trend shows a decline, influenced by its performance relative to moving averages and the significant year-to-date drop, despite some positive signs in investor participation.

View full answer

What does Galaxy Medicare do?

01-Sep-2026

Galaxy Medicare Ltd is a micro-cap healthcare services company incorporated in 1992, with a market cap of INR 26 Cr. Key financial metrics include a P/E ratio of 8.00, a dividend yield of 1.76%, and a return on equity of 14.16%.

Overview: <BR>Galaxy Medicare Ltd operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History: <BR>Galaxy Medicare Limited was incorporated on July 23, 1992, in the Mancheshwar Industrial area of Bhubaneswar, Orissa. The company commenced its operations in the same year. There is no information available regarding status changes or the latest quarter for which sales and profit are reported.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 26 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 8.00 <BR>Industry P/E: 112 <BR>Dividend Yield: 1.76% <BR>Debt-Equity: 0.17 <BR>Return on Equity: 14.16% <BR>Price-to-Book: 1.07 <BR><BR>Contact Details: <BR>Address: Not available <BR>Phone: Not available <BR>Email: Not available <BR>Website: Not available

View full answer

Who are the peers of the Galaxy Medicare?

01-Sep-2026

Galaxy Medicare's peers include Sunrest Lifescie, Chennai Meena, Adeshwar Meditex, Tejnaksh Health, and others. Management risk is excellent for Galaxy Medicare and Sunrest Lifescie, while growth is below average for Galaxy Medicare and several peers.

Peers: The peers of Galaxy Medicare are Sunrest Lifescie, Chennai Meena, Adeshwar Meditex, Tejnaksh Health., Samsrita Labs, GKB Ophthalmics, Transgene Biotek, Vanta Bioscience, Deccan Healthcar.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sunrest Lifescie and Galaxy Medicare, while Below Average management risk is found at Adeshwar Meditex, Tejnaksh Health., and GKB Ophthalmics, and the rest. Growth is Excellent at Sunrest Lifescie, Below Average at Galaxy Medicare, Adeshwar Meditex, Tejnaksh Health., Vanta Bioscience, and the rest, while Chennai Meena, Samsrita Labs, and Transgene Biotek do not qualify. Capital Structure is Good at Galaxy Medicare, GKB Ophthalmics, and Deccan Healthcar, Average at Adeshwar Meditex, Below Average at Tejnaksh Health., Vanta Bioscience, and the rest.<BR><BR>Return Snapshot: GKB Ophthalmics has the highest 1-year return at N/A, while Sunrest Lifescie has the lowest at -19.51%, and Galaxy Medicare's 1-year return is also N/A. Additionally, Sunrest Lifescie and Vanta Bioscience have negative six-month returns.

View full answer

Which are the latest news on Galaxy Medicare?

01-Sep-2026
No latest news for Galaxy Medicare found.

How big is Galaxy Medicare?

14-Aug-2026

Summary could not be generated.

As of 14th August, Galaxy Medicare Ltd has a market capitalization of 30.12 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent quarterly performance data is unavailable, so there are no figures for Net Sales or Net Profit for the latest four quarters.<BR><BR>The reporting period for the balance sheet is March 2025, with Shareholder's Funds amounting to 24.15 Cr and Total Assets valued at 31.49 Cr.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 26 Cr (Micro Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

116

stock-summary
Dividend Yield

1.76%

stock-summary
Debt Equity

0.17

stock-summary
Return on Equity

14.16%

stock-summary
Price to Book

1.07

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.76%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.92%
0%
-13.92%
6 Months
4.29%
0%
4.29%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Latest dividend: 0.3 per share ex-dividend date: Dec-17-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Galaxy Medicare Ltd has declared 3% dividend, ex-date: 17 Dec 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
8.40%
EBIT Growth (5y)
-6.32%
EBIT to Interest (avg)
4.08
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0
Tax Ratio
27.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
17.35%

Valuation key factors

Factor
Value
P/E Ratio
8
Industry P/E
0
Price to Book Value
1.07
EV to EBIT
8.14
EV to EBITDA
7.08
EV to Capital Employed
1.06
EV to Sales
0.75
PEG Ratio
NA
Dividend Yield
1.76%
ROCE (Latest)
13.00%
ROE (Latest)
14.16%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

D.k. Das And Sons (huf) (16.12%)

Highest Public shareholder

None

Individual Investors Holdings

24.37%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Galaxy Medicare"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Mar 2026 is 13.56% vs -14.71% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Mar 2026 is -30.69% vs 21.69% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "21.27",
          "val2": "18.73",
          "chgp": "13.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.36",
          "val2": "2.86",
          "chgp": "-52.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.16",
          "val2": "0.11",
          "chgp": "45.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.40",
          "val2": "2.02",
          "chgp": "-30.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.39%",
          "val2": "15.27%",
          "chgp": "-8.88%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Galaxy Medicare"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 2.04% vs 8.44% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 1.48% vs -9.16% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "40.00",
          "val2": "39.20",
          "chgp": "2.04%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.22",
          "val2": "4.65",
          "chgp": "-9.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.28",
          "val2": "0.69",
          "chgp": "-59.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.42",
          "val2": "3.37",
          "chgp": "1.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.55%",
          "val2": "11.86%",
          "chgp": "-1.31%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Half Yearly Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Sep'25
Change(%)
Net Sales
21.27
18.73
13.56%
Operating Profit (PBDIT) excl Other Income
1.36
2.86
-52.45%
Interest
0.16
0.11
45.45%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.40
2.02
-30.69%
Operating Profit Margin (Excl OI)
6.39%
15.27%
-8.88%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Mar 2026 is 13.56% vs -14.71% in Sep 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Mar 2026 is -30.69% vs 21.69% in Sep 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
40.00
39.20
2.04%
Operating Profit (PBDIT) excl Other Income
4.22
4.65
-9.25%
Interest
0.28
0.69
-59.42%
Exceptional Items
0.00
0.00
Standalone Net Profit
3.42
3.37
1.48%
Operating Profit Margin (Excl OI)
10.55%
11.86%
-1.31%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 2.04% vs 8.44% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 1.48% vs -9.16% in Mar 2025

stock-summaryCompany CV
About Galaxy Medicare Ltd stock-summary
stock-summary
Galaxy Medicare Ltd
Micro Cap
Healthcare Services
Galaxy Medicare Limited was originally established on July 23, 1992 as a Limited Company in the Mancheshwar Industrial area of Bhubaneswar, Orissa. The Company commenced its operations in 1992 when the founder, Mr.
Company Coordinates stock-summary
Icon
No Company Details Available